Lundberg J
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
PreprintPsilocybin
Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled Trial
ArticlePsilocybin
CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.
ArticlePsilocybin
Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial.
ArticlePsilocybin
Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression.
ArticlePsilocybin
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.
ArticlePsilocybin
[Psychedelic psychiatry].
ArticlePsilocybin
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.
ArticlePsilocybin